All Stories

  1. Effects of basic and dual-task training programs on physical function in Parkinson’s disease: The PARKEX study

    Article • PLOS One, September 2026, PLOS

    Joel Montane

  2. Physical activity and human islet amyloid polypeptide islet amyloidosis: mechanistic plausibility, missing evidence, and future directions

    Article • Endocrinology, August 2026, Endocrine Society

    Joel Montane

  3. Effects of high-intensity interval training and concurrent training on body composition and metabolic profile in postmenopausal women with overweight or obesity: a clinical trial

    Article • Exploration of Endocrine and Metabolic Diseases, April 2026, Open Exploration Publishing

    Joel Montane

  4. Analyzing motivation for tele-exercise in adult fitness app users

    Article • mHealth, October 2025, AME Publishing Company

    Joel Montane

  5. Survival analysis for predicting fitness app user churn

    Article • mHealth, October 2025, AME Publishing Company

    Joel Montane

  6. Analysis of training behavior in users of a fitness app: a cross-sectional study (Preprint)

    Article • February 2025, JMIR Publications Inc.

    Joel Montane

  7. Analysis of training behavior in users of a fitness app: a cross-sectional study. (Preprint)

    Article • JMIR mhealth and uhealth, February 2025, JMIR Publications Inc.

    Joel Montane

  8. A protocol study to investigate the role of physical activity in patients with Parkinson disease

    Article • PLOS One, November 2023, PLOS

    Joel Montane, Susana Pereira

  9. Aerobic exercise training reduces deep-frying oil-induced apoptosis of hippocampal tissue by reducing oxidative stress in male rats

    Article • Journal of Chemical Neuroanatomy, November 2023, Elsevier

    Joel Montane

  10. Investigating the impact of physical activity on mitochondrial function in Parkinson’s disease (PARKEX): Study protocol for a randomised controlled clinical trial

    Article • October 2023, Cold Spring Harbor Laboratory Press

    Joel Montane

  11. Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease

    Article • Biomedicines, December 2022, MDPI AG

    Joel Montane

  12. Adherence to eHealth-Delivered Exercise in Adults with no Specific Health Conditions: A Scoping Review on a Conceptual Challenge

    Article • International Journal of Environmental Research and Public Health, August 2022, MDPI AG

    Joel Montane

  13. Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

    Article • Redox Biology, August 2022, Elsevier

    PhD Pablo M. Garcia-Roves, Joel Montane

  14. Predicting Physical Exercise Adherence in Fitness Apps Using a Deep Learning Approach

    Article • International Journal of Environmental Research and Public Health, October 2021, MDPI AG

    Joel Montane

  15. 4-Phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity

    Article • Scientific Reports, June 2021, Springer Science + Business Media

    Joel Montane

  16. Hurdles of environmental risk assessment procedures for advanced therapy medicinal products: comparison between the European Union and the United States

    Article • Critical Reviews in Toxicology, December 2019, Taylor & Francis

    Joel Montane

  17. Prevention of autoimmune diabetes and islet allograft rejection by beta cell expression of XIAP: Insight into possible mechanisms of local immunomodulation

    Article • Molecular and Cellular Endocrinology, December 2018, Elsevier

    Joel Montane

  18. Stress-Induced MicroRNA-708 Impairs β-Cell Function and Growth

    Article • Diabetes, October 2017, American Diabetes Association

    Joel Montane

  19. Amyloid-induced β-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment

    Article • The FASEB Journal, August 2017, Federation of American Societies For Experimental Biology (FASEB)

    Joel Montane

  20. BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression

    Article • Cellular and Molecular Life Sciences, March 2017, Springer Science + Business Media

    Joel Montane

  21. Protein disulfide isomerase ameliorates β-cell dysfunction in pancreatic islets overexpressing human islet amyloid polypeptide

    Article • Molecular and Cellular Endocrinology, January 2016, Elsevier

    Joel Montane

  22. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance

    Article • Cell Transplantation, October 2015, SAGE Publications

    Joel Montane

  23. Amyloid Formation in Human Islets Is Enhanced by Heparin and Inhibited by Heparinase

    Article • Arabian archaeology and epigraphy, June 2015, Elsevier

    Joel Montane

  24. Islet amyloid polypeptide exerts a novel autocrine action in β‐cell signaling and proliferation

    Article • The FASEB Journal, March 2015, Wiley

    Joel Montane

  25. Inhibition of BACE2 counteracts hIAPP‐induced insulin secretory defects in pancreatic β‐cells

    Article • The FASEB Journal, October 2014, Wiley

    Joel Montane

  26. Chaperones Ameliorate Beta Cell Dysfunction Associated with Human Islet Amyloid Polypeptide Overexpression

    Article • PLOS One, July 2014, PLOS

    Joel Montane

  27. Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes

    Article • Diabetes Metabolic Syndrome and Obesity, February 2014, Taylor & Francis

    Joel Montane

  28. Treatment of Diabetes and Long-Term Survival After Insulin and Glucokinase Gene Therapy

    Article • Diabetes, April 2013, American Diabetes Association

    Joel Montane

  29. Metabolic stress, IAPP and islet amyloid

    Article • Diabetes Obesity and Metabolism, August 2012, Wiley

    Joel Montane

  30. Molecular signature of the immune and tissue response to non-coding plasmid DNA in skeletal muscle after electrotransfer

    Article • Gene Therapy, December 2011, Springer Science + Business Media

    Joel Montane

  31. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets

    Article • Journal of Clinical Investigation, August 2011, American Society for Clinical Investigation

    Joel Montane

  32. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency

    Article • Gene Therapy, December 2009, Springer Science + Business Media

    Joel Montane

  33. Reversal of Type 1 Diabetes by Engineering a Glucose Sensor in Skeletal Muscle

    Article • Diabetes, June 2006, American Diabetes Association

    Joel Montane

  34. In vivo Gene Transfer to Healthy and Diabetic Canine Pancreas

    Article • Molecular Therapy, April 2006, Elsevier

    Joel Montane